| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.16 | 0.007 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.093 | 0.008 |